tiprankstipranks
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
US Market

Arrowhead Pharmaceuticals (ARWR) Income Statement

Compare
1,491 Followers

Arrowhead Pharmaceuticals Income Statement

Last quarter (Q1 2025), Arrowhead Pharmaceuticals's total revenue was $2.50M, a decrease of -29.60% from the same quarter last year. In Q1, Arrowhead Pharmaceuticals's net income was $-173.09M. See Arrowhead Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
$ 3.55M$ 240.74M$ 243.23M$ 138.29M$ 87.99M
Gross Profit
$ 3.55M$ 240.74M$ 232.81M$ 138.29M$ 87.99M
Operating Expenses
$ 604.63M$ 445.74M$ 421.74M$ 287.32M$ 181.15M
Depreciation and Amortization
$ 18.59M$ 12.49M$ 10.42M$ 8.27M$ 5.94M
EBITDA
$ -561.51M$ -175.67M$ -162.29M$ -132.58M$ -87.22M
Operating Income
$ -601.08M$ -205.00M$ -178.51M$ -149.04M$ -93.16M
Other Income/Expenses
$ -11.38M$ -1.49M$ 5.80M$ 8.19M$ 8.61M
Pretax Income
$ -612.46M$ -206.49M$ -172.71M$ -140.85M$ -84.55M
Net Income
$ -599.49M$ -205.28M$ -176.49M$ -140.85M$ -84.55M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.00$ -1.91$ -1.67$ -1.36$ -0.84
Diluted EPS
$ -5.00$ -1.92$ -1.67$ -1.36$ -0.84
Weighted Average Shares Outstanding
119.78M 107.31M 105.43M 103.75M 100.72M
Weighted Average Shares Outstanding (Diluted)
119.78M 106.75M 105.43M 103.75M 100.72M
Currency in USD

Arrowhead Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis